Research & Development Our Current Projects: Currently we are associated with Multi National Company for its project (Phase III) in the field of Nephrology, Gynaecology and with another MNC for its post market surveillance in oncology specialty. This shows clinical research/pharma industry's faith upon us for precise and reliable data. Ongoing Trials: Study No. EFC10547: A Multinational, Randomized, Double-blind Study Comparing the Efficacy of Aflibercept Once every 2 weeks versus Placebo in Patients Treated with Gemcitabine for Metastatic Pancreatic Cancer Patient (MPC). Study No. DOCET_R_02271: This is a multi-country, multi-centre, single arm non-interventional, prospective registry study. Active implementation of Quality of Life (QOL) assessment in clinical practice for patients with advanced NSCLC and comparison of QOL and response endpoints. Study No. EFC6521: This is a multinational, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of Study Drug in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy.